the Safety and Efficacy of Meplazumab in Patients With COVID-19

NCT05113784 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: Meplazumab for Injection
DRUG: Sterile normal saline (0.9%)

Sponsor

Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd